Importantly, MT‐01 was shown to ameliorate scopolamine‐induced memory impairment in behavioral tests, increase SOD activity, and decrease AChE activity in mice, compared to scopolamine‐treated mice with no MT‐01 administration. This evidence concerns the gene SOD1 and memory impairment.